Guanglei Chang
Impact in
-
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
-
- Diabetes Treatment and Management
Papers in
-
- Cardiac Fibrosis and Remodeling 3
- Cardiovascular Function and Risk Factors 2
- Co-authors
- Shu Qin (9 shared papers)Ying Wang (6 shared papers)Dongying Zhang (3 shared papers)Kai Lü (8 shared papers)Peng Zhang (4 shared papers)Dongying Zhang (7 shared papers)Lei Gao (6 shared papers)Aihua Zheng (3 shared papers)
- Journals
- BMC Cardiovascular Disorders (3 papers)International Journal of Molecular Medicine (2 papers)Frontiers in Pharmacology (1 paper)Journal of Molecular Medicine (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Guanglei Chang
22 papers receiving 631 citations
Peers
Comparison fields: 5 of 75
- Cardiology and Cardiovascular Medicine 152
- Endocrinology, Diabetes and Metabolism 110
- Pathology and Forensic Medicine 92
- Geriatrics and Gerontology 13
- Molecular Biology 227
Countries citing papers authored by Guanglei Chang
This map shows the geographic impact of Guanglei Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanglei Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanglei Chang more than expected).
Fields of papers citing papers by Guanglei Chang
This network shows the impact of papers produced by Guanglei Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanglei Chang. The network helps show where Guanglei Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guanglei Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 100 | |
| 2 | 2018 | 90 | |
| 3 | 2013 | 74 | |
| 4 | 2020 | 55 | |
| 5 | 2013 | 53 | |
| 6 | 2014 | 49 | |
| 7 | 2017 | 43 | |
| 8 | 2019 | 41 | |
| 9 | 2021 | 34 | |
| 10 | 2016 | 29 | |
| 11 | 2019 | 15 | |
| 12 | 2015 | 11 | |
| 13 | 2017 | 9 | |
| 14 | 2016 | 8 | |
| 15 | 2018 | 6 | |
| 16 | Facilitation of endothelial cell growth on hydroxylated ePTFE vascular grafts. | 1992 | 6 |
| 17 | 2018 | 4 | |
| 18 | 2021 | 3 | |
| 19 | 2023 | 2 | |
| 20 | 2022 | 2 |
About Guanglei Chang
Guanglei Chang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery and Pathology and Forensic Medicine, having authored 23 papers that have together received 636 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (3 papers), Cardiac Ischemia and Reperfusion (3 papers), Cardiac Fibrosis and Remodeling (3 papers), Cardiovascular Function and Risk Factors (2 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper), Infectious Aortic and Vascular Conditions (1 paper), Adenosine and Purinergic Signaling (1 paper) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (152 citations), Endocrinology, Diabetes and Metabolism (110 citations), Pathology and Forensic Medicine (92 citations), Geriatrics and Gerontology (13 citations) and Molecular Biology (227 citations). Guanglei Chang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Shu Qin, Ying Wang, Dongying Zhang, Kai Lü, Peng Zhang, Dongying Zhang, Lei Gao, Aihua Zheng, Liyou Wang and Jian Liu. Their work appears in journals such as BMC Cardiovascular Disorders, International Journal of Molecular Medicine, Frontiers in Pharmacology, Journal of Molecular Medicine and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.